Product Code: GVR-4-68040-201-7
Demineralized Bone Matrix Market Growth & Trends:
The global demineralized bone matrix market size is expected to reach USD 1.97 billion by 2030, registering a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to the increasing investment of the government in the advancement of research related to orthopedic diseases. For instance, in 2021, the Orthopedic Surgery program at the Perelman School of Medicine, University of Pennsylvania, secured over USD 10 million in NIH grants, further demonstrating the significance of this area of research.
Increasing prevalence of spinal cord injuries across the globe is anticipated to boost market growth. According to the NIH report of 2022, an estimated 250,000 to 500,000 individuals globally suffer from spinal cord injuries every year. Most of these cases are preventable and are caused by factors such as trauma and motor vehicle accidents. In the United States alone, about 17,000 new spinal cord injury cases are reported annually, with an estimated 282,000 individuals living with SCI. Males are more likely to experience SCI due to sports injuries, and the age group with the highest risk is between 16 to 30 years old.
The increasing prevalence of orthopedic disorders across the globe is expected to boost market growth. For instance, the Lancet Rheumatology estimates published in 2023 indicate that by 2050, almost one billion individuals will be diagnosed with osteoarthritis, the most prevalent type of arthritis. Similarly, as per the GVR internal data base, in 2023, the number of people affected with osteoarthritis are 11.4 million in 2023. Such rising cases of orthopedic disorders will boost the demand for demineralized bone matrix (DBM).
The major players operating in the market are adopting strategies such as collaborations, supply agreements, and partnerships with a major focus on enhancing product formation and reach. For instance, in March 2022, Bone Biologics Corporation, a developer of orthobiologic products, signed a supply agreement with MTF Biologics. The agreement is for the supply of demineralized bone matrix (DBM). Bone Biologics is developing a bone graft substitute product that consists of rhNELL-1 and a carrier, which will be supplied by MTF Biologics. The product aims to initiate and improve bone formation.
Additionally, a growing patient base with an increasing aging population will supplement market growth. For instance, according to an NIH report, osteoarthritis (OA) is a joint disease that affects more than 80% of individuals over the age of 55. In addition, as per the NHIS report from 2019 to 2021 in the U.S., 26% of adults between the ages of 45 and 64 reported being diagnosed with arthritis by a doctor. The report also found that almost half (47.3%) of adults aged 65 or older reported being diagnosed with arthritis by a doctor.
Demineralized Bone Matrix Market Report Highlights:
- Based on product type, the putty segment held the largest revenue share in the market in 2023 owing to the moldable consistency of DBM putty to tailor the graft to fit specific defect sites with precision
- Based on application, the joint reconstruction segment is anticipated to grow at the fastest growth rate over the forecast period in the market owing to the rising cases of joint reconstruction among the population
- Based on end-use, the outpatient facilities segment accounted for the largest revenue share due to the growing preference for outpatient treatment
- North America dominated the market due to the presence of key market players coupled with the increasing prevalence of orthopedic disorders, spinal injuries, and a rising geriatric population
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product type outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Demineralized Bone Matrix (DBM) Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Demineralized Bone Matrix (DBM): Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
- 3.4. Regulatory Framework
Chapter 4. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Product Type, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Product Type Market Share Analysis, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Demineralized Bone Matrix (DBM) Market, by Product Type, 2018 to 2030
- 4.5. Putty
- 4.5.1. Putty market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Fiber
- 4.6.1. Fiber market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Sponge
- 4.7.1. Sponge market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Paste
- 4.8.1. Paste market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.9. Gel
- 4.9.1. Gel market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.10. Others
- 4.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Demineralized Bone Matrix (DBM) Market, by Application, 2018 to 2030
- 5.5. Spinal Fusion
- 5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Dental
- 5.6.1. Dental market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Joint Reconstruction
- 5.7.1. Joint reconstruction market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Hand, foot, and ankle
- 5.8.1. Hand, foot, and ankle market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.9. Long Bone
- 5.9.1. Long bone market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.10. Craniomaxillofacial
- 5.10.1. Craniomaxillofacial market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Demineralized Bone Matrix (DBM) Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)
- 6.1. Definition and Scope
- 6.2. End-use Market Share Analysis, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Demineralized Bone Matrix (DBM) Market, by end-use, 2018 to 2030
- 6.5. Hospitals
- 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Outpatient facilities
- 6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.2. Specialized Orthopedic Clinics
- 6.6.2.1. Specialized orthopedic clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6.3. Ambulatory Surgical Centers
- 6.6.3.1. Ambulatory surgical centers clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Demineralized Bone Matrix (DBM) Market Segment Analysis, By Region, By Product Type, By Application, By End Use, 2018- 2030 (USD Million)
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Regional Market Snapshot
- 7.4. Demineralized Bone Matrix (DBM) Market Share by Region, 2023 & 2030:
- 7.5. North America
- 7.5.1. North America demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. U.S. demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Canada demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. UK demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Germany demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. France demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Italy demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Spain demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Norway demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Sweden demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Denmark demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Japan demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. China demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. India demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Australia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. South Korea demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Thailand demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Brazil demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Mexico demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Argentina demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. South Africa demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Saudi Arabia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. UAE demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Kuwait demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Profiles
- 8.3.1. Zimmer Biomet
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Medtronic Plc
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. DePuy Synthes
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Stryker Corporation
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Arthrex Inc
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. SeaSpine
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Globus Medical
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Berkeley Advanced Biomaterials
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. XTANT MEDICAL
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. LifeNet Health
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives